Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03119077
Recruitment Status : Terminated (Study early terminated due to lower drug exposure)
First Posted : April 18, 2017
Last Update Posted : May 17, 2018
Sponsor:
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 8, 2017
Actual Study Completion Date : January 31, 2018